Wedge Capital Management L L P NC Boosts Stake in Select Medical Holdings Co. (NYSE:SEM)

Wedge Capital Management L L P NC increased its position in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 66.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 118,049 shares of the health services provider's stock after acquiring an additional 46,925 shares during the quarter. Wedge Capital Management L L P NC owned about 0.09% of Select Medical worth $2,225,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Quarry LP purchased a new position in shares of Select Medical in the third quarter worth about $30,000. Canada Pension Plan Investment Board purchased a new position in Select Medical in the 2nd quarter valued at approximately $39,000. DekaBank Deutsche Girozentrale bought a new stake in Select Medical during the 2nd quarter valued at $60,000. GAMMA Investing LLC lifted its position in shares of Select Medical by 16.6% during the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider's stock worth $81,000 after acquiring an additional 330 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Select Medical in the third quarter worth $81,000. 89.48% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now owns 30,356 shares in the company, valued at $605,602.20. This trade represents a 14.12 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the company's stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now owns 22,000 shares of the company's stock, valued at approximately $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 17.50% of the company's stock.

Select Medical Price Performance

Shares of NYSE SEM traded down $0.09 during midday trading on Monday, hitting $19.09. 545,589 shares of the company's stock were exchanged, compared to its average volume of 952,939. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The business's fifty day moving average price is $23.13 and its two-hundred day moving average price is $30.93. The company has a market cap of $2.47 billion, a price-to-earnings ratio of 8.92, a PEG ratio of 0.61 and a beta of 1.45. Select Medical Holdings Co. has a 12-month low of $18.02 and a 12-month high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.46 EPS. As a group, research analysts forecast that Select Medical Holdings Co. will post 1.97 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were given a dividend of $0.125 per share. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a yield of 2.62%. Select Medical's payout ratio is 23.36%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on SEM shares. Benchmark cut Select Medical from a "buy" rating to a "hold" rating in a report on Monday, November 25th. UBS Group lowered their price target on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a report on Friday, January 3rd. Royal Bank of Canada raised their price objective on shares of Select Medical from $40.00 to $47.00 and gave the company an "outperform" rating in a research report on Monday, November 4th. Finally, StockNews.com cut shares of Select Medical from a "buy" rating to a "hold" rating in a research note on Wednesday, January 15th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $39.50.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.